High-dose regimen of interleukin-2 and interferon-alpha in combination with lymphokine-activated killer cells in patients with metastatic renal cell cancer

Wim Kruit, SH (Swan Hoo) Goey, CHJM Lamers, JW (S.) Gratama, B@ Visser, PIM@ Schmitz, Lex Eggermont, RLH (Reinder) Bolhuis, Gerrit Stoter

Research output: Contribution to journalArticleAcademicpeer-review

21 Citations (Scopus)
27 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)312-320
Number of pages9
JournalJournal of Immunotherapy
Issue number4
Publication statusPublished - 1997

Research programs

  • EMC 04-01-DD-11-01
  • EMC 04-01-DD-12-01

Cite this